254.58
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$252.65
Aprire:
$255
Volume 24 ore:
469.22K
Relative Volume:
0.28
Capitalizzazione di mercato:
$58.95B
Reddito:
$250.74B
Utile/perdita netta:
$1.55B
Rapporto P/E:
38.93
EPS:
6.5398
Flusso di cassa netto:
$4.39B
1 W Prestazione:
+6.20%
1M Prestazione:
+12.96%
6M Prestazione:
+20.55%
1 anno Prestazione:
+61.87%
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CAH
Cardinal Health Inc
|
254.58 | 58.95B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
MCK
Mckesson Corp
|
1,020.22 | 118.95B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
342.41 | 65.34B | 328.68B | 2.55B | 1.56B | 13.03 |
|
HSIC
Henry Schein Inc
|
84.42 | 9.41B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.3686 | 1.17B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-08-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-04-28 | Iniziato | William Blair | Outperform |
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Cardinal Health stock: Baird's USD 276.00 target leaves Cardinal Health stock 8.09 percent below it - ad-hoc-news.de
Cardinal Health extends CVS deal. Cardinal Health stock costs EUR 226.20 not valid? wait - ad-hoc-news.de
Could Cardinal Health (NYSE:CAH) Be in Focus After Wall Street’s Latest Rotation? - Kalkine Media
Cardinal Health (CAH) Laps the Stock Market: Here's Why - Zacks Investment Research
Cardinal Health (CAH) Laps the Stock Market: Here's Why - Yahoo Finance
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge - Zacks Investment Research
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cardinal Health Inc (CAH) Shares Surge 3.4% -- What GF Score of 78 Tells Investors - GuruFocus
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Deals tracker: Harbor Health to buy 27 Village Medical clinics - Modern Healthcare
What to Expect From Cardinal Health’s Q1 2027 Earnings Report - Yahoo Finance
What to Expect From Cardinal Health’s Q1 2027 Earnings Report - inkl
Cardinal Health, Inc. (CAH) options chain – Yahoo Finance - Yahoo Finance Singapore
Cardinal Health Could Benefit From RayzeBio's Phase 3 Success, RBC Says - www.marketscreener.com
Here's Why Cardinal Health (CAH) is a Strong Growth Stock - Zacks Investment Research
Are Medical Stocks Lagging Cardinal Health (CAH) This Year? - Yahoo Finance
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
China Patient Examination Devices Market Size, Share, and Forecast to 2033Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide Expansion - GlobeNewswire Inc.
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Zacks Investment Research
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Freehand CEO Nitin Jayakrishnan Addresses Supply Chain Disruption and Resilience at LogiPharma USA 2026 - GlobeNewswire Inc.
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Yahoo Finance
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know - Zacks Investment Research
Cardinal Health stock gains 1.59 percent after CVS pact - AD HOC NEWS
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo! Finance Canada
Cardinal Health agrees to extend CVS deal: Cardinal Health stock gains 1.33 percent - AD HOC NEWS
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex - Zacks Investment Research
CVS renews as Cardinal Health’s largest customer through 2032 - bizjournals.com
Is Cardinal Health Inc (CAH) Overvalued After 3.4% Rally? GF Val - gurufocus.com
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo Finance
Cardinal Health, Inc. (CAH) Stock Forecasts - Yahoo! Finance Canada
Cardinal Health rises on extended CVS distribution deal - Investing.com
Cardinal Health, McKesson Extend Distribution Pacts With CVS Through 2032 - finance.biggo.com
McKesson and Cardinal Health: CVS Contract Renewal Reaffirms Narrow Moat and Long-Term Growth - Morningstar
Why Is Cardinal Health and McKesson Stock Trading Higher TodayCVS Health (NYSE:CVS), McKesson (NYSE:MC - Benzinga
Why Is Cardinal Health and McKesson Stock Trading Higher TodayCVS Health (NYSE:CVS), McKesson (NYSE:MC - Benzinga
Cardinal Health renews contract with CVS Health - marketscreener.com
Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032 - Yahoo Finance
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve - Zacks Investment Research
Cardinal Health (CAH) Extends CVS Distribution Deal Through 2032, Reaffirms FY2027 EPS Guidance - gurufocus.com
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health - Yahoo Finance
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5 - Yahoo! Finance Canada
Cardinal Health rises on extended CVS distribution deal - Yahoo Finance
Cardinal Health: I'm Still Buying After Checking The Numbers (NYSE:CAH) - Seeking Alpha
Total debt per share of Cardinal Health, Inc. – HAN:CLH - TradingView
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail
At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend? - TradingView
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cardinal Health Inc Azioni (CAH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hollar Jason M. | Chief Executive Officer |
Aug 19 '26 |
Sale |
236.18 |
44,529 |
10,516,660 |
190,603 |
| Mary Scherer | Officer |
Aug 19 '26 |
Proposed Sale |
237.39 |
2,302 |
546,462 |
0 |
| WEITZMAN DEBORAH | CEO, PSS Segment |
Aug 18 '26 |
Sale |
235.45 |
7,354 |
1,731,524 |
77,901 |
| Alt Aaron E | Chief Financial Officer |
Aug 18 '26 |
Sale |
236.34 |
42,000 |
9,926,140 |
20,495 |
| Mayer Jessica L | Chief Legal/Compliance Officer |
Aug 18 '26 |
Sale |
236.19 |
29,436 |
6,952,485 |
33,076 |
| Greene Michelle D. | Chief Information Officer |
Aug 18 '26 |
Sale |
235.72 |
11,650 |
2,746,187 |
10,330 |
| Aaron Alt | Officer |
Aug 18 '26 |
Proposed Sale |
236.34 |
42,000 |
9,926,183 |
0 |
| Michelle Greene | Officer |
Aug 18 '26 |
Proposed Sale |
235.72 |
11,650 |
2,746,148 |
0 |
| Deborah Weitzman | Officer |
Aug 18 '26 |
Proposed Sale |
235.45 |
7,354 |
1,731,534 |
0 |
| Jessica Mayer | Officer |
Aug 18 '26 |
Proposed Sale |
236.19 |
29,436 |
6,952,441 |
0 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):